STAGE-ORIENTED TREATMENT OF NONSEMINOMATOUS TESTICULAR-TUMOR

被引：3
作者：
DERIGS, HG [1 ]
HUBER, C [1 ]
SCHMOLL, HJ [1 ]
机构：
[1] HANNOVER MED SCH,ZENTRUM INNERE MED & DERMATOL,HAMAT & ONKOL ABT,D-30625 HANNOVER,GERMANY
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 1994年 / 119卷 / 05期
关键词：
D O I：
10.1055/s-2008-1058675
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：156 / 164
页数：9
相关论文
共 43 条
[1]   RANDOMIZED TRIAL OF ETOPOSIDE AND CISPLATIN VERSUS ETOPOSIDE AND CARBOPLATIN IN PATIENTS WITH GOOD-RISK GERM-CELL TUMORS - A MULTIINSTITUTIONAL STUDY [J].
BAJORIN, DF ;
SAROSDY, MF ;
PFISTER, DG ;
MAZUMDAR, M ;
MOTZER, RJ ;
SCHER, HI ;
GELLER, NL ;
FAIR, WR ;
HERR, H ;
SOGANI, P ;
SHEINFELD, J ;
RUSSO, P ;
VLAMIS, V ;
CAREY, R ;
VOGELZANG, NJ ;
CRAWFORD, ED ;
BOSL, GJ .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) :598-606
[2]   SERUM MARKERS IN GERM-CELL NEOPLASMS [J].
BARTLETT, NL ;
FREIHA, FS ;
TORTI, FM .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1991, 5 (06) :1245-1260
[3]  
BOKEMEYER C, 1993, EUR UROL, V23, P223
[4]   LACK OF LATE TOXICITY IN PATIENTS TREATED WITH CISPLATIN-CONTAINING COMBINATION CHEMOTHERAPY FOR METASTATIC TESTICULAR CANCER [J].
BOYER, M ;
RAGHAVAN, D ;
HARRIS, PJ ;
LIETCH, J ;
BLEASEL, A ;
WALSH, JC ;
ANDERSON, S ;
TSANG, CS .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (01) :21-26
[5]   REPORT ON THE INTERNATIONAL WORKSHOP ON STAGING AND TREATMENT OF TESTICULAR CANCER [J].
CAVALLI, F ;
MONFARDINI, S ;
PIZZOCARO, G .
EUROPEAN JOURNAL OF CANCER, 1980, 16 (10) :1367-1372
[6]   THE MUNICH FOLLOW-UP PROGRAM IN ADVANCED NONSEMINOMATOUS TESTICULAR-TUMORS [J].
CLEMM, C ;
BERDEL, WE ;
HARTENSTEIN, R ;
NISENBAUM, J ;
FINK, U ;
RASTETTER, J ;
WILMANNS, W .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (31-32) :1181-1185
[7]   TREATMENT OF NON-SEMINOMATOUS TESTICULAR-TUMOR IN STAGE-I-IIB [J].
CLEMM, C ;
SAUER, H ;
HARTENSTEIN, R .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1989, 114 (34) :1276-1282
[8]  
DIECKMANN KP, 1989, UROLOGE A, V28, P271
[9]  
Donohue J P, 1991, Prog Urol, V1, P389
[10]  
DONOHUE JP, 1978, CANCER-AM CANCER SOC, V42, P2903, DOI 10.1002/1097-0142(197812)42:6<2903::AID-CNCR2820420653>3.0.CO
12345